Time filter

Source Type

Udaondo P.,Polytechnic University of Valencia | Garcia-Delpech S.,Polytechnic University of Valencia | Matinez-Costa R.,Polytechnic University of Valencia | Navarro-Piera J.,Francesc de Borja Hospital | Cisneros-Lanuza A.,Polytechnic University of Valencia
Expert Review of Ophthalmology | Year: 2014

Different intravitreal anti-VEGF medications have been used for the management of retinal vascular disorders with highly satisfactory results and good safety profiles. Aflibercept, a new anti-VEGF drug with a different mechanism of action compared with prior therapies, has recently emerged. The results of aflibercept Phase II and III studies show its efficacy for the treatment of wet age-related macular degeneration, macular edema secondary to central retinal vein occlusion and diabetic macular edema. © 2014 Informa UK, Ltd. Source

Discover hidden collaborations